You have 9 free searches left this month | for more free features.

City

Wuhan (2)

Changchun (1)

Hangzhou (1)

Nanjing (1)

Shanghai (1)

Wuxi (1)

Condition

Dwarfism (1)

GHD (1)

Growth Retardation (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Phase

phase 2 (1)

phase 3 (1)

phase 4 (1)

Sponsor

GeneScience Pharmaceuticals Co., Ltd. (2)

Changchun GeneScience Pharmaceutical Co., Ltd. (1)

Collaborator

Affiliated Hospital of Jiangnan University (1)

Children's Hospital of Fudan University (1)

Shanghai Children's Hospital (1)

The Children's Hospital of Zhejiang University School of Medicine (1)

The First Affiliated Hospital with Nanjing Medical University (1)

The First Hospital of Jilin University (1)

Tongji Hospital (1)

Intervention

peg-somatropin (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

peg-somatropin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

GHD Trial (PEG-somatropin)

Not yet recruiting

PEG-somatropin

(no location specified)

Sep 7, 2023

Growth Retardation Trial in Wuhan (PEG-somatropin)

Unknown status

Growth Retardation

PEG-somatropin

Wuhan, Hubei, China

TongJi hospital affiliated to TongJi medical college of HuaZhong

Dec 10, 2017

Dwarfism Trial in China (PEG-somatropin)

Recruiting

Dwarfism

PEG-somatropin

Wuhan, Hubei, China
+6 more

Aug 16, 2017